US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

CTH

Citigroup Fdg (CTH)

Citigroup Fdg

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:CTH

1

Fecha	Hora	Fuente	Título	Símbolo	Compañía
15/08/2016	05:00	GlobeNewswire	Cynapsus Announces Positive Opinion from Data and Safety Monitoring Board on Phase 3 Parkinson's Disease Clinical Study Allow...	AMEX:CTH	Citigroup Fdg
18/07/2016	15:10	GlobeNewswire	Cynapsus Therapeutics Announces Positive Phase 3 Dose Titration Phase Results with APL-130277 for the Treatment of OFF Episod...	AMEX:CTH	Citigroup Fdg
30/06/2016	07:00	GlobeNewswire	Cynapsus Therapeutics Enrolls Last Patient in Pivotal Phase 3 Efficacy Trial of APL-130277 to Treat OFF Episodes in Patients ...	AMEX:CTH	Citigroup Fdg
30/05/2016	01:00	GlobeNewswire	Cynapsus Therapeutics Announces Data Presentations at the European Academy of Neurology Annual Meeting	AMEX:CTH	Citigroup Fdg
15/04/2016	05:00	GlobeNewswire	Cynapsus Therapeutics Announces Data Presentations at the American Academy of Neurology Annual Meeting	AMEX:CTH	Citigroup Fdg
08/12/2015	01:00	GlobeNewswire	Cynapsus Therapeutics Announces Positive Data Presentations at World Congress on Parkinson's Disease and Related Disorders Me...	AMEX:CTH	Citigroup Fdg
17/07/2014	15:15	GlobeNewswire	Cynapsus Therapeutics Inc : Cynapsus Therapeutics Commences Phase 2 Clinical Trials in the United States	AMEX:CTH	Citigroup Fdg
08/07/2014	00:00	GlobeNewswire	Cynapsus Therapeutics Inc. : Cynapsus Therapeutics Awarded Second Grant from The Michael J. Fox Foundation for Parkinson's Re...	AMEX:CTH	Citigroup Fdg
14/05/2014	05:00	GlobeNewswire	Cynapsus Therapeutics Inc. : Cynapsus Announces No Buccal Mucosal Irritation in FDA Registration Study of APL-130277 for Park...	AMEX:CTH	Citigroup Fdg
24/04/2014	05:00	GlobeNewswire	Cynapsus Therapeutics Inc. : Cynapsus Announces Positive Results of CTH-104 Clinical Study of APL-130277 for Parkinson's Dise...	AMEX:CTH	Citigroup Fdg
28/03/2014	05:00	GlobeNewswire	Cynapsus Therapeutics Inc. : Cynapsus Announces Interim Summary Results of Human Healthy Volunteer Single 25mg Study for APL-...	AMEX:CTH	Citigroup Fdg
13/01/2014	05:00	GlobeNewswire	Cynapsus Therapeutics Inc. : Cynapsus Announces Completion of Human Healthy Volunteer Crossover Study Results for APL-130277	AMEX:CTH	Citigroup Fdg
15/05/2013	00:00	GlobeNewswire	Cynapsus Therapeutics Inc. : Cynapsus Therapeutics Publishes White Paper on Apomorphine for 'Off' Periods in Parkinson's Dise...	AMEX:CTH	Citigroup Fdg
24/03/2006	10:00	PR Newswire (US)	American Stock Exchange Lists Citigroup Funding Inc.'s 7.5% Sequins Linked to UnitedHealth Group Inc.	AMEX:CTH

Showing the most relevant articles for your search:AMEX:CTH

1

Invesco QQQ Trust Series 1

Bank of America

Euro vs US Dollar

US Dollar vs MXN

Verizon Communications

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones